Re: Should patients with primary upper urinary tract cancer receive prophylactic intravesical chemotherapy after nephroureterectomy?: W. J. Wu, H. L. Ke, Y. H. Yang, C. C. Li, Y. H. Chou and C. H. Huang J Urol 2010; 183: 56-61.
Mouracade
Pascal
P
D000283:Administration, Intravesical; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D006801:Humans; D007680:Kidney Neoplasms / Q000517:prevention & control* / Q000601:surgery; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control*; D016609:Neoplasms, Second Primary / Q000517:prevention & control*; D009392:Nephrectomy; D014513:Ureter / Q000601:surgery*; D014516:Ureteral Neoplasms / Q000517:prevention & control* / Q000601:surgery; D001749:Urinary Bladder Neoplasms / Q000517:prevention & control*
D000970:Antineoplastic Agents